5325402026-04-012026-06-305325402026-06-305325402026-04-012026-06-30in-capmkt:OtherExpenses1Member5325402026-04-012026-06-30in-capmkt:OtherExpenses2Member5325402026-04-012026-06-30in-capmkt:ReportableSegments1Member5325402026-04-012026-06-30in-capmkt:ReportableSegments2Member5325402026-04-012026-06-30in-capmkt:ReportableSegments3Member5325402026-04-012026-06-30in-capmkt:ReportableSegments4Member5325402026-04-012026-06-30in-capmkt:ReportableSegments5Member5325402026-04-012026-06-30in-capmkt:ReportableSegments6Member5325402026-04-012026-06-30in-capmkt:ReportableSegments1Member5325402026-04-012026-06-30in-capmkt:ReportableSegments2Member5325402026-04-012026-06-30in-capmkt:ReportableSegments3Member5325402026-04-012026-06-30in-capmkt:ReportableSegments4Member5325402026-04-012026-06-30in-capmkt:ReportableSegments5Member5325402026-04-012026-06-30in-capmkt:ReportableSegments6Member5325402026-04-012026-06-30in-capmkt:ReportableSegments1Member5325402026-06-30in-capmkt:ReportableSegments1Member5325402026-04-012026-06-30in-capmkt:ReportableSegments2Member5325402026-06-30in-capmkt:ReportableSegments2Member5325402026-04-012026-06-30in-capmkt:ReportableSegments3Member5325402026-06-30in-capmkt:ReportableSegments3Member5325402026-04-012026-06-30in-capmkt:ReportableSegments4Member5325402026-06-30in-capmkt:ReportableSegments4Member5325402026-04-012026-06-30in-capmkt:ReportableSegments5Member5325402026-06-30in-capmkt:ReportableSegments5Member5325402026-04-012026-06-30in-capmkt:ReportableSegments6Member5325402026-06-30in-capmkt:ReportableSegments6Member5325402026-04-012026-06-30in-capmkt:ReportableSegments1Member5325402026-06-30in-capmkt:ReportableSegments1Member5325402026-04-012026-06-30in-capmkt:ReportableSegments2Member5325402026-06-30in-capmkt:ReportableSegments2Member5325402026-04-012026-06-30in-capmkt:ReportableSegments3Member5325402026-06-30in-capmkt:ReportableSegments3Member5325402026-04-012026-06-30in-capmkt:ReportableSegments4Member5325402026-06-30in-capmkt:ReportableSegments4Member5325402026-04-012026-06-30in-capmkt:ReportableSegments5Member5325402026-06-30in-capmkt:ReportableSegments5Member5325402026-04-012026-06-30in-capmkt:ReportableSegments6Member5325402026-06-30in-capmkt:ReportableSegments6Member5325402026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15325402026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25325402026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15325402026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss25325402026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss35325402026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss45325402026-04-012026-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares532540TCSNOTLISTEDINE467B01029Tata Consultancy Services LimitedMain BoardEquity2026-04-012027-03-312026-07-092026-06-22INRCroresQuarterlyFirst quarterMulti segment2026-07-0910:15:002026-07-0915:45:00Declaration of unmodified opinion2026-04-012026-06-30AuditedConsolidated72275000000015680000000738430000000000421370000000273000000012390000000115820000000552310000000186120000000-668000000017944000000047220000000-1980000000452400000000134200000000000013420000000025300000001367300000001334900000007100000001360900000006400000003620000000136.936.90036.936.9000Cost of equipment and software licences13540000000Other expenses102280000000Banking, Financial Services and Insurance279900000000Manufacturing71100000000Consumer Business111460000000Communication, Media and Technology106140000000Life Sciences and Healthcare74290000000Others79860000000722750000000722750000000Banking, Financial Services and Insurance71770000000Manufacturing19830000000Consumer Business33080000000Communication, Media and Technology28450000000Life Sciences and Healthcare18340000000Others1409000000018556000000027300000003390000000179440000000Banking, Financial Services and Insurance0Manufacturing0Consumer Business0Communication, Media and Technology0Life Sciences and Healthcare0Others0000Banking, Financial Services and Insurance0Manufacturing0Consumer Business0Communication, Media and Technology0Life Sciences and Healthcare0Others0000Remeasurement of defined employee benefit plans-1210000000Net change in fair values of investments in equity shares carried at fair value through OCI20000000-1190000000-240000000Net change in fair values of investments other than equity shares carried at fair value through OCI5380000000Net change in intrinsic value of derivatives designated as cash flow hedges760000000Net change in time value of derivatives designated as cash flow hedges-50000000Exchange differences on translation of financial statements of foreign operations-1080000000501000000015300000002530000000AuditedtrueB S R & Co. LLPtrue2028-07-31